• Home
  • Contact Us!
  • Privacy Policy

Radio Metta

  • Home
  • Business
  • Education
  • Health
  • Home Deco
  • News
  • Real Estate
  • Technology
  • Contact Us!
  • Privacy Policy
Home» Health»Widely used type 2 diabetes drug may reduce cancer death risk

Widely used type 2 diabetes drug may reduce cancer death risk

Saheli 17 Apr 2016 Health Comments Off on Widely used type 2 diabetes drug may reduce cancer death risk 371 Views

FRIDAY, April 15, 2016 — Metformin, a commonly prescribed diabetes drug, may reduce the risk of dying from some cancers for postmenopausal women with type 2 diabetes, a new study suggests.

The study found that for women with type 2 diabetes and cancer, the odds of dying from cancer appeared to be 45 percent higher compared to women with cancer who didn’t have diabetes. But, in women with cancer who took metformin to treat their type 2 diabetes, the risk of dying from cancer seemed about the same as it was for women without diabetes.

“Our findings from this large study may provide more evidence that postmenopausal women with diabetes and cancer may benefit from metformin therapy compared to other anti-diabetes therapy,” said lead researcher Zhihong Gong. She’s an assistant professor of oncology at the Roswell Park Cancer Institute, in Buffalo, N.Y.

Gong cautioned, however, that this study didn’t prove that metformin prevents or reduces the risk of dying from cancer, only that an association was found. And, she added that more studies are necessary to figure out metformin’s possible role in decreasing the risk of dying from cancer.

The report was published in the April 15 print issue of the International Journal of Cancer.

Metformin is a first-line drug in the treatment of type 2 diabetes, the American Diabetes Association (ADA) says. People with type 2 diabetes don’t use the hormone insulin efficiently, which leads the pancreas to pump out more and more insulin until it eventually fails, the ADA explains. Insulin is a hormone that’s necessary for the body to use the carbohydrates in food as fuel. Metformin makes the body more sensitive to insulin and reduces insulin resistance, the researchers said.

The study team reviewed data from nearly 146,000 postmenopausal women. They were between the ages of 50 and 79. The information was collected between 1993 and 1998 and came from the large Women’s Health Initiative study.

The researchers wanted to focus on women with type 2 in this study. So, in an effort to exclude women with type 1 diabetes, the researchers removed information on anyone who had been diagnosed with diabetes before age 21.

Looking at specific cancers, the risk for postmenopausal women with diabetes appeared to be about 25 percent to 35 percent higher for developing colon and endometrial cancers and non-Hodgkin lymphoma. The women’s risk was more than doubled for liver and pancreatic cancers, the researchers found.

“Our findings suggest that diabetes remains a risk factor for cancer and cancer-related death, and metformin therapy, compared to other diabetes medications, may have an important role in [managing] diabetes-associated cancer,” Gong said.

One diabetes expert who wasn’t involved with the study was cautious about interpreting the results.

Although the study found a slight risk reduction, it depended on taking the drug for a long time, said Dr. Joel Zonszein, director of the Clinical Diabetes Center at Montefiore Medical Center in New York City. More studies are in progress to determine the long-term effect of metformin in cancer risk, he added.

“We still don’t understand the exact mechanism of action of this old drug used in diabetes,” Zonszein said. “It may have positive effects in decreasing cancer mortality and or increasing longevity as shown in this paper.”

[Source:- UPI]

2 cancer death diabetes Drug may reduce risk type used Widely 2016-04-17
Tags 2 cancer death diabetes Drug may reduce risk type used Widely
Facebook Twitter Stumble linkedin Pinterest More

Authors

Posted by : Saheli
Previous Article :

Social Club at Harvard Rejects Calls to Admit Women, Citing Risk of Sexual Misconduct

Next Article :

Iowa puts faith in wind energy

Related Articles

How is PSA used to monitor prostate cancer?

How is PSA used to monitor prostate cancer?

admin 01 Sep 2025
Anatomy, Function, and Common Injuries of Hamstring Muscles

Anatomy, Function, and Common Injuries of Hamstring Muscles

admin 12 Aug 2025
Quitting vaping: the health reasons why you should give up vaping

Quitting vaping: the health reasons why you should give up vaping

admin 30 Jul 2025

Latest Post

How is PSA used to monitor prostate cancer?
Health

How is PSA used to monitor prostate cancer?

admin 01 Sep 2025
The Future of High Performance Networking: Ultra Ethernet Explained
Technology

The Future of High Performance Networking: Ultra Ethernet Explained

admin 28 Aug 2025
Why a focus on foundational education must be at the heart of the response: Out of school but not out of reach
Education

Why a focus on foundational education must be at the heart of the response: Out of school but not out of reach

admin 23 Aug 2025
HP Increases Innovation in Gaming
Technology

HP Increases Innovation in Gaming

admin 19 Aug 2025
Anatomy, Function, and Common Injuries of Hamstring Muscles
Health

Anatomy, Function, and Common Injuries of Hamstring Muscles

admin 12 Aug 2025
Gaming Your Way to Sharper AI Prompts
Technology

Gaming Your Way to Sharper AI Prompts

admin 07 Aug 2025
15 Elegant Living Room Hanging Lights
Home Deco

15 Elegant Living Room Hanging Lights

admin 04 Aug 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Aug    
  • Home
  • Contact Us!
  • Privacy Policy
Copyright 2016, All Rights Reserved
Magazine Blog News WordPress Theme